| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Soleno Therapeutics, Inc. (SLNO) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 31 sells. SLNO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 469.5K | $24.86M | - | |
| CFO | 103.2K | $5.46M | - | |
| Other | 67.2K | $3.56M | - | |
| VP | 40.3K | $2.13M | - | |
| Other | 27.2K | $1.44M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 27, 2026 | Huang Michael F. | Sr. VP Of Clinical Development | Sell | 6,582 | $30.44 | $200,364.78 | -5.1% | - | - | |
| Mar 27, 2026 | Manning Meredith | Chief Commercial Officer | Sell | 7,522 | $30.44 | $228,979.64 | -3.7% | - | - | |
| Jul 1, 2025 | Hirano Patricia C | See Remarks | Sell | 3,830 | $82.76 | $316,970.80 | -22.5% | -17.5% | - | |
| Jun 24, 2025 | Hirano Patricia C | See Remarks | Sale+OE | 266 | $84.25 | $22,410.50 | -1.5% | -32.8% | - | |
| Apr 1, 2025 | Hirano Patricia C | See Remarks | Sell | 3,782 | $70.11 | $265,156.02 | -12.3% | +22.7% | -45.8% | |
| Mar 28, 2025 | Pauls Matthew66 | Director | Sale+OE | 5,937 | $71.55 | $424,797.10 | -47.7% | +16.7% | -58.3% | |
| Mar 28, 2025 | Hirano Patricia C | See Remarks | Sale+OE | 27,662 | $69.40 | $1,919,635.72 | -14.6% | +16.7% | -58.3% | |
| Mar 28, 2025 | Vivo Opportunity, LLC67 | 10% Owner | Sell | 333,557 | $70.60 | $23,549,124.20 | -7.0% | +16.7% | -58.3% | |
| Mar 27, 2025 | Yen Kristen | See Remarks | Sale+OE | 93,043 | $66.75 | $6,210,648.42 | -18.1% | +27.3% | -55.4% | |
| Mar 27, 2025 | Manning Meredith | Chief Commercial Officer | Sale+OE | 45,249 | $67.28 | $3,044,342.88 | -9.5% | +27.3% | -55.4% |